MedPath

Neurocognitive Benefits of a Weight Management Program

Phase 4
Completed
Conditions
Overweight and Obesity
Interventions
Behavioral: Waitlist
Behavioral: WW (formerly Weight Watchers)
Registration Number
NCT04202133
Lead Sponsor
University of Pennsylvania
Brief Summary

This study will assess whether weight loss induced through diet and physical activity can change neural responses to high- and low-calorie food images. In addition, it will evaluate whether weight loss can improve neural function when performing the N-back task, a measure of working memory. Findings will address notable gaps in the literature by testing whether a scalable weight loss intervention can help protect and improve neurocognitive functioning and brain health in individuals with obesity. This study will also provide important information about the effects of weight loss on neuroplasticity in brain regions crucial for memory and cognitive functioning, which will help to inform future interventions aimed at promoting brain health.

Detailed Description

The purpose of the present study is to conduct a randomized controlled trial (RCT) to assess the effects of a commercially available weight loss program (WW; formerly Weight Watchers) on neural response to food cues and memory tasks, as well as on structural brain morphology. Participants with obesity will be randomized to either 16 weeks of an in-person, group-based WW program (n=30) or a wait-list control (WLC; n=30). Both groups will have structural and blood oxygen level-dependent (BOLD) functional magnetic resonance imaging (fMRI) scans at baseline and after the 16-week intervention. Participants will complete the following fMRI tasks: 1) structural scan; 2) food cue task to measure reactivity to high and low-calorie food images and 3) N-back task to measure working memory (i.e., the ability to temporarily hold information available for processing). In addition, participants will complete self-report and behavioral measures of eating behaviors, appetite, physical activity, mood, quality of life, attention and memory at baseline, and weeks 8 and 16.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
61
Inclusion Criteria
  • Ages 18-60 years

  • Female

  • BMI>30 kg/m2

  • Eligible female patients will be:

    • Non-pregnant
    • Non-lactating
    • Surgically sterile or postmenopausal, or they will agree to continue to use an accepted method of birth control during the study. Acceptable methods of birth control are: hormonal contraceptives; double barrier method (condom with spermicide or diaphragm with spermicide); intrauterine device; surgical sterility; abstinence; and/or postmenopausal status (defined as at least 2 years without menses).
  • Participants must:

    • Understand and be willing to comply with all study-related procedures and agree to participate in the study by giving written informed consent
Exclusion Criteria
  • Weight>158.8 kg (350 lbs, due to scanner weight restrictions)
  • Serious medical risk such as type 1 or 2 diabetes, cancer, or recent cardiac event (e.g., heart attack, angioplasty)
  • Untreated thyroid disease or any changes (type or dose) in thyroid medication in the last 6 months
  • Current psychiatric disorder that significantly interferes with daily living
  • Active suicidal ideation
  • Current substance use disorder (current or in remission < 1 year)
  • Presence or history of orthopedic circumstances, metallic inserts, pacemaker, claustrophobia, or other conditions that may interfere with magnetic resonance imaging
  • Participation in a structured weight loss program in the prior 6 months
  • WW member within the past 12 months
  • Use of medications known to induce significant weight loss/gain, including chronic use of oral steroids in the past 3 months
  • Psychiatric hospitalization within the past 6 months
  • Loss of >10 lbs of body weight within the past 3 months
  • History or plans for bariatric surgery
  • Visual, auditory, or other impairment affecting task performance
  • Epilepsy
  • Neurological trauma (e.g., concussion)
  • Inability to attend treatment and/or assessment visits
  • Participant from same household
  • Adherence to specialized diet regimes, such as vegetarian, macrobiotic
  • Lack of capacity to provide informed consent
  • Inability to walk 5 blocks comfortably or engage in some other form of aerobic activity (e.g., swimming)
  • Any serious or unstable medical or psychological condition that, in the opinion of the investigator, would compromise the patient's safety or successful participation in the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Waitlist ControlWaitlist16-weeks on waitlist then participants will be provided with 16-weeks of the group-based WW program
WW (formerly Weight Watchers)WW (formerly Weight Watchers)16-weeks of the group-based WW program
Primary Outcome Measures
NameTimeMethod
Blood Oxygen Level-dependent (BOLD) Response to High-calorie Foods Cues Minus Neutral Objects in Left Anterior Cingulate CortexChange from baseline to 16 weeks

Changes in BOLD fMRI response to high-calorie food images

Reward-based EatingChange from baseline to 16 weeks

Changes in scores on the Reward-Based Eating Drive Scale; range of 0-52; higher scores indicate higher reward-related eating

Food Cravings- Trait (Lack of Control Over Eating)Change from baseline to 16 weeks

Changes in scores on the Food Cravings Questionnaire- Trait (lack of control over eating), range=6-36, higher scores indicate greater cravings

Food PreferenceChange from baseline to 16 weeks

Changes in scores on the Leeds Food Preference Questionnaire

Eating BehaviorsChange from baseline to 16 weeks

Changes in scores on the Eating Behaviors Questionnaire (liking for high-calorie foods); visual analog scores ranging from 0-100 with higher scores indicating a worse outcome

Hippocampal VolumeChange from baseline to 16 weeks

Change in hippocampal volume

BOLD fMRI Response to the N-back TaskChange from baseline to 16 weeks

Changes in BOLD fMRI response to the N-back task

Eating Behaviors (Low-calorie Foods)Change from baseline to 16 weeks

Changes in scores on the Eating Behaviors Questionnaire (liking for low-calorie foods); visual analog scores ranging from 0-100 with higher scores indicating a better outcome

Secondary Outcome Measures
NameTimeMethod
Eating BehaviorChange from baseline to 16 weeks

Changes in eating behavior as measured by the Eating Inventory (Cognitive restraint, disinhibited eating, and hunger subscales, summed scores, higher values indicate greater restraint/disinhibition/hunger). The cognitive restraint scale includes 21 items (range 0-21). Higher scores demonstrate more awareness of one's eating and success in restricting dietary intake for weight control. The disinhibited eating scale includes 16 items (range 0-16). Higher scores signify more overeating tendencies. The hunger scale has 14 items and higher scores indicate more perceived hunger (range 0-14). Subscales were analyzed separately.

N-back Behavioral PerformanceChange from baseline to 16 weeks

Change in reaction time (seconds) on the N-back task

Percent WeightChange from baseline to 16 weeks

Percent weight change

Power of FoodChange from baseline to 16 weeks

Changes in eating behavior as measured by the Power of Food Scale; higher scores indicate greater hedonic hunger. Range of scores is 1-5

Trial Locations

Locations (1)

University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath